Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Caris Life Sciences

Request full access

A profiling platform that identifies novel molecular targets to inform and enhance drug development and advanced diagnostics

Irving, United StatesFounded 1996Biotech & Life Sciences

About Caris Life Sciences

Caris Life Sciences is a pioneering company that operates at the intersection of molecular science and artificial intelligence, with a primary focus on revolutionizing cancer care. The company provides comprehensive molecular information to cancer patients and oncologists, aiding in the development of personalized treatment plans. This is achieved by understanding the molecular features of a cancer when the diagnosis is made, which can provide insights into how the cancer may behave and what treatments may be most effective.

Caris Life Sciences' business model is centered on providing high-quality, reliable molecular information to help improve the lives of as many people as possible. The company's clients are primarily oncologists and cancer patients, but also include researchers and payors in the healthcare sector. The company generates revenue by offering its transformative technologies and services to these clients, thereby helping them navigate, advance, and reinvent cancer care.

The company is committed to quality and innovation, and this is reflected in its hiring practices. Caris Life Sciences seeks to employ the brightest minds in scientific, medical, and professional fields to help fulfill the promise of personalized medicine. The company's dedication to its mission is evident in the opportunities it provides to its employees, as well as in the positive experiences shared by team members.

In summary, Caris Life Sciences is a leading innovator in molecular science, using artificial intelligence to revolutionize cancer care by providing comprehensive molecular information to patients, oncologists, researchers, and payors.

Source: Dealroom company data

At a glance

Status
Listed
Listing
IPO 2025

Caris Life Sciences in the Irving ecosystem

Live from Dealroom

The Caris Life Sciences office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

23 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series B and later23 investors entered at this stage

Employees mapped 1,694 incl. 27 AI specialists
Founders Hidden — book a demo/100 quality score
Key operators 10 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Patents

Estimated portfolio value
$40M

23 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

See Caris Life Sciences on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.